CRMT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CRMT is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading below its pivot with bearish moving averages, weak recent financial performance, and reduced analyst expectations. Even though hedge funds are buying, the overall setup does not support an immediate buy for an impatient investor. Best direct call: do not buy now.
The technical picture is weak. Price is 12.2, slightly below the pivot at 13.047 and close to support at 11.924. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. RSI_6 at 42.626 is neutral but still below the midpoint, showing limited momentum. MACD histogram is positive at 0.202 but contracting, which suggests upside momentum is fading rather than strengthening. The short-term trend model also points lower, with a 60% chance of -1.68% next day, -5.38% next week, and -1.59% next month.
Hedge funds are buying aggressively, with buying amount up 14186.49% over the last quarter. Gross margin improved to 49.47%, up 4.32% YoY, which suggests some operating efficiency improvement. The stock is near support levels, which may attract value-oriented interest if sentiment improves.
No news in the recent week, so there is no fresh catalyst supporting a rebound. Jefferies lowered its price target sharply to $14 from $29 and kept a Hold rating, citing funding constraints, weather impacts, and a tough macro backdrop with sticky inflation/rates and subprime scrutiny. Revenue in 2026/Q3 fell 11.95% YoY, net income dropped to -76.713M, and EPS fell to -9.25, showing major earnings deterioration. Insider activity is neutral. Congress trading data shows no recent activity. The overall trend remains bearish.
In 2026/Q3, America's Car-Mart reported weakening fundamentals. Revenue fell to 286.792M, down 11.95% YoY, while net income declined to -76.713M, a sharp deterioration of -2533.79% YoY. EPS also dropped to -9.25, down -2600.00% YoY. The only notable improvement was gross margin, which rose to 49.47%, up 4.32% YoY. Overall, the latest quarter shows shrinking sales and significant losses despite better margins.
Recent analyst sentiment turned more cautious. On 2026-03-17, Jefferies cut its price target on CRMT to $14 from $29 and maintained a Hold rating. The firm attributed weakness to funding constraints and weather, not demand, but still highlighted macro pressure and subprime-sector scrutiny. Wall Street's pros view: gross margin improvement and some operational resilience. Cons view: earnings losses, revenue decline, funding limits, and a reduced target that signals limited near-term upside.
